Li01 administration alleviated 5-FU-induced diarrhea by mitigating inflammation and oxidative damage, and restoring intestinal barrier. Li01 exerted its benefits by elevating the level of gut microbiota-derived IPA, which activated the PXR.
Yin et al. (2026) studied this question.